Hansa Medical trades up after €66m block

In an otherwise barren week for block trades, Hansa Medical, the Swedish biotechnology company, raised Skr399.8m of fresh capital to fund product development. The deal also provided an opportunity for Nexttobe AB to sell a portion of its stake in the company.

  • By Aidan Gregory, Sam Kerr
  • 14 Nov 2018

Cowen & Co, RBC Capital Markets and SEB were bookrunners.

The deal consisted of 1.77m new shares and 888,382 shares sold by Nexttobe, the largest shareholder in Hansa. It was priced at Skr225, a 16.6% discount to the closing price of Hansa on Tuesday, valuing the sale ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

All International Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 29,036.25 83 9.38%
2 JPMorgan 26,957.68 80 8.71%
3 Barclays 19,404.68 52 6.27%
4 BNP Paribas 19,264.87 42 6.22%
5 HSBC 19,097.04 63 6.17%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Bank of America Merrill Lynch 9,498.80 2 86.56%
2 Swedbank 160.81 1 1.47%
2 Sumitomo Mitsui Financial Group 160.81 1 1.47%
2 SEB 160.81 1 1.47%
2 Nordea 160.81 1 1.47%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 ING 220.22 2 13.96%
1 Bank of America Merrill Lynch 220.22 2 13.96%
1 ABN AMRO Bank 220.22 2 13.96%
4 Barclays 129.04 1 8.18%
5 Morgan Stanley 114.77 1 7.28%